Literature DB >> 22491945

Bcl11a is required for neuronal morphogenesis and sensory circuit formation in dorsal spinal cord development.

Anita John1, Heike Brylka, Christoph Wiegreffe, Ruth Simon, Pentao Liu, René Jüttner, E Bryan Crenshaw, Frank P Luyten, Nancy A Jenkins, Neal G Copeland, Carmen Birchmeier, Stefan Britsch.   

Abstract

Dorsal spinal cord neurons receive and integrate somatosensory information provided by neurons located in dorsal root ganglia. Here we demonstrate that dorsal spinal neurons require the Krüppel-C(2)H(2) zinc-finger transcription factor Bcl11a for terminal differentiation and morphogenesis. The disrupted differentiation of dorsal spinal neurons observed in Bcl11a mutant mice interferes with their correct innervation by cutaneous sensory neurons. To understand the mechanism underlying the innervation deficit, we characterized changes in gene expression in the dorsal horn of Bcl11a mutants and identified dysregulated expression of the gene encoding secreted frizzled-related protein 3 (sFRP3, or Frzb). Frzb mutant mice show a deficit in the innervation of the spinal cord, suggesting that the dysregulated expression of Frzb can account in part for the phenotype of Bcl11a mutants. Thus, our genetic analysis of Bcl11a reveals essential functions of this transcription factor in neuronal morphogenesis and sensory wiring of the dorsal spinal cord and identifies Frzb, a component of the Wnt pathway, as a downstream acting molecule involved in this process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22491945      PMCID: PMC4067532          DOI: 10.1242/dev.072850

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  51 in total

Review 1.  Specification of dorsal spinal cord interneurons.

Authors:  Amy W Helms; Jane E Johnson
Journal:  Curr Opin Neurobiol       Date:  2003-02       Impact factor: 6.627

Review 2.  The formation of sensorimotor circuits.

Authors:  Martyn Goulding; Guillermo Lanuza; Tamar Sapir; Sujatha Narayan
Journal:  Curr Opin Neurobiol       Date:  2002-10       Impact factor: 6.627

3.  Development of GABAergic and glycinergic transmission in the neonatal rat dorsal horn.

Authors:  Mark L Baccei; Maria Fitzgerald
Journal:  J Neurosci       Date:  2004-05-19       Impact factor: 6.167

4.  Lmx1b controls the differentiation and migration of the superficial dorsal horn neurons of the spinal cord.

Authors:  Yu-Qiang Ding; Jun Yin; Artur Kania; Zhong-Qiu Zhao; Randy L Johnson; Zhou-Feng Chen
Journal:  Development       Date:  2004-06-30       Impact factor: 6.868

5.  Characterization of Frzb-Cre transgenic mouse.

Authors:  Przemko Tylzanowski; Wouter Bossuyt; J Terrig Thomas; Frank P Luyten
Journal:  Genesis       Date:  2004-12       Impact factor: 2.487

6.  Bcl11a is essential for normal lymphoid development.

Authors:  Pentao Liu; Jonathan R Keller; Mariaestela Ortiz; Lino Tessarollo; Rivka A Rachel; Takuro Nakamura; Nancy A Jenkins; Neal G Copeland
Journal:  Nat Immunol       Date:  2003-04-28       Impact factor: 25.606

7.  A highly efficient recombineering-based method for generating conditional knockout mutations.

Authors:  Pentao Liu; Nancy A Jenkins; Neal G Copeland
Journal:  Genome Res       Date:  2003-03       Impact factor: 9.043

8.  Anterior-posterior guidance of commissural axons by Wnt-frizzled signaling.

Authors:  Anna I Lyuksyutova; Chin-Chun Lu; Nancy Milanesio; Leslie A King; Nini Guo; Yanshu Wang; Jeremy Nathans; Marc Tessier-Lavigne; Yimin Zou
Journal:  Science       Date:  2003-12-12       Impact factor: 47.728

9.  The human tissue plasminogen activator-Cre mouse: a new tool for targeting specifically neural crest cells and their derivatives in vivo.

Authors:  Thomas Pietri; Olivier Eder; Martine Blanche; Jean Paul Thiery; Sylvie Dufour
Journal:  Dev Biol       Date:  2003-07-01       Impact factor: 3.582

10.  Tlx3 and Tlx1 are post-mitotic selector genes determining glutamatergic over GABAergic cell fates.

Authors:  Leping Cheng; Akiko Arata; Rumiko Mizuguchi; Ying Qian; Asanka Karunaratne; Paul A Gray; Satoru Arata; Senji Shirasawa; Maxime Bouchard; Ping Luo; Chih-Li Chen; Meinrad Busslinger; Martyn Goulding; Hiroshi Onimaru; Qiufu Ma
Journal:  Nat Neurosci       Date:  2004-04-04       Impact factor: 24.884

View more
  33 in total

1.  BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations.

Authors:  Anindita Basak; Miroslava Hancarova; Jacob C Ulirsch; Tugce B Balci; Marie Trkova; Michal Pelisek; Marketa Vlckova; Katerina Muzikova; Jaroslav Cermak; Jan Trka; David A Dyment; Stuart H Orkin; Mark J Daly; Zdenek Sedlacek; Vijay G Sankaran
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

Review 2.  Gene therapy for sickle cell disease: An update.

Authors:  Selami Demirci; Naoya Uchida; John F Tisdale
Journal:  Cytotherapy       Date:  2018-05-30       Impact factor: 5.414

3.  Ctip1 Controls Acquisition of Sensory Area Identity and Establishment of Sensory Input Fields in the Developing Neocortex.

Authors:  Luciano C Greig; Mollie B Woodworth; Chloé Greppi; Jeffrey D Macklis
Journal:  Neuron       Date:  2016-04-20       Impact factor: 17.173

Review 4.  Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders.

Authors:  Daniel E Bauer; Sophia C Kamran; Stuart H Orkin
Journal:  Blood       Date:  2012-08-17       Impact factor: 22.113

5.  An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.

Authors:  Daniel E Bauer; Sophia C Kamran; Samuel Lessard; Jian Xu; Yuko Fujiwara; Carrie Lin; Zhen Shao; Matthew C Canver; Elenoe C Smith; Luca Pinello; Peter J Sabo; Jeff Vierstra; Richard A Voit; Guo-Cheng Yuan; Matthew H Porteus; John A Stamatoyannopoulos; Guillaume Lettre; Stuart H Orkin
Journal:  Science       Date:  2013-10-11       Impact factor: 47.728

Review 6.  Fetal globin gene repressors as drug targets for molecular therapies to treat the β-globinopathies.

Authors:  Mikiko Suzuki; Masayuki Yamamoto; James Douglas Engel
Journal:  Mol Cell Biol       Date:  2014-07-14       Impact factor: 4.272

Review 7.  Fetal haemoglobin induction in sickle cell disease.

Authors:  Alireza Paikari; Vivien A Sheehan
Journal:  Br J Haematol       Date:  2017-11-16       Impact factor: 6.998

Review 8.  Customizing the genome as therapy for the β-hemoglobinopathies.

Authors:  Matthew C Canver; Stuart H Orkin
Journal:  Blood       Date:  2016-04-06       Impact factor: 22.113

9.  Time-lapse Confocal Imaging of Migrating Neurons in Organotypic Slice Culture of Embryonic Mouse Brain Using In Utero Electroporation.

Authors:  Christoph Wiegreffe; Svenja Feldmann; Simeon Gaessler; Stefan Britsch
Journal:  J Vis Exp       Date:  2017-07-25       Impact factor: 1.355

10.  The transcriptional repressor BCL11A promotes breast cancer metastasis.

Authors:  Darcie D Seachrist; Molly M Hannigan; Natasha N Ingles; Bryan M Webb; Kristen L Weber-Bonk; Peng Yu; Gurkan Bebek; Salendra Singh; Steven T Sizemore; Vinay Varadan; Donny D Licatalosi; Ruth A Keri
Journal:  J Biol Chem       Date:  2020-06-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.